fitusiran
fitusiran is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Qfitlia. Available dosage form: injection, solution.
Drug Details
- Generic Name
- fitusiran
- Brand Names
- Qfitlia
- Application Number
- NDA219019
- Sponsor
- Genzyme Corporation
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- FITUSIRAN
Indications and Usage
1 INDICATIONS AND USAGE QFITLIA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without factor VIII or IX inhibitors. QFITLIA is an antithrombin-directed small interfering ribonucleic acid indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without factor VIII or IX inhibitors. ( 1 )